6 results on '"Yuan, Yaping"'
Search Results
2. Low serum levels of insulin-like growth factor-1 are associated with an increased risk of rheumatoid arthritis: a systematic review and meta-analysis.
- Author
-
Yang, Jiajia, Yuan, Yaping, Hu, Xingxing, Han, Renfang, Chen, Mengya, Wang, Mengmeng, Zhang, Xu, Ma, Yubo, Wu, Meng, Zou, Yanfeng, Pan, Guixia, Liu, Rui, Jiang, Guangming, Xu, Shengqian, Shuai, Zongwen, and Pan, Faming
- Subjects
- *
RHEUMATOID arthritis risk factors , *CONFIDENCE intervals , *META-analysis , *SOMATOMEDIN , *SYSTEMATIC reviews , *CONNECTIVE tissue growth factor , *DESCRIPTIVE statistics - Abstract
Insulin-like growth factor-1 (IGF-1) and insulin-like growth factor binding protein-3 (IGFBP-3) are not only involved in individual growth and metabolism, but they are also associated with inflammation and homeostasis of articular cartilage and bone. Recent studies have identified the involvement of IGF-1 and IGFBP-3 in the development of rheumatoid arthritis (RA). Nevertheless, the results were inconsistent, and the relevant data were not synthetically assessed. Therefore, this review aimed to systematically evaluate the associations of serum IGF-1 and IGFBP-3 levels with the development of RA. Several databases were used to retrieve relevant publications (up to January 2018). Pooled standard mean difference (SMD) and 95% confidence interval (CI) were demonstrated using a forest plot. A total of 27 studies from 19 publications were included. Meta-analysis results showed that RA patients had lower serum IGF-1 levels when compared to controls (SMD = −0.650, 95% CI = −1.184 to −0.115, P =.017). However, there was no significant association between serum IGFBP-3 levels and RA (SMD = 0.590, 95% CI = −1.323 to 2.504, P =.545). Subgroup analyses further showed that serum IGF-1 levels in RA patients are discrepant in terms of race, age, and measurement type (all P <.05). In conclusion, the decreased levels of serum IGF-1 were closely associated with the development of RA. Future longitudinal studies are needed to validate the link between serum IGF-1 levels with RA pathogenesis as well as the effects of IGF-1 on RA treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
3. Elevated circulating IL-17 level is associated with inflammatory arthritis and disease activity: A meta-analysis.
- Author
-
Zhang, Xu, Yuan, Yaping, Pan, Zhipeng, Ma, Yubo, Wu, Meng, Yang, Jiajia, Han, Renfang, Chen, Mengya, Hu, Xingxing, Liu, Rui, Sam, Napoleon Bellua, Xu, Shengqian, and Pan, Faming
- Subjects
- *
ARTHRITIS , *ANKYLOSING spondylitis , *META-analysis , *PSORIATIC arthritis , *RHEUMATOID arthritis , *DATABASE searching - Abstract
Previous studies found that the interleukin (IL)-17 level was elevated in inflammatory arthritis, but results were inconsistent. This meta-analysis aimed to investigate the association of IL-17 cytokine with osteoarthritis (OA), rheumatoid arthritis (RA), ankylosing spondylitis (AS) and psoriatic arthritis (PsA). Relevant studies were searched using databases. Standardized mean difference (SMD) was calculated. Correlation coefficient was utilized to evaluate the relationship between IL-17 and disease activity of AS and RA. Subgroup analysis, sensitivity analysis and meta-regression were applied to explore the sources of heterogeneity. 83 records were enrolled. The IL-17 level was elevated in AS (SMD = 2.348, P <.001), RA (SMD = 1.502, P <.001), PsA (SMD = 1.710, P <.001) and OA (SMD = 1.192, P =.016), and similar results occurred in subgroup analysis. Furthermore, the IL-17 level was positively associated with disease activity of AS and RA. Circulating IL-17 level is significantly elevated in inflammatory arthritis and is related to the disease activity of AS and RA, suggesting that it plays an important role in the pathogenesis and progression of inflammatory arthritis (especially in AS and RA). • IL-17 was elevated in Asians and Caucasians AS and RA patients. • IL-17 was elevated in large and small sample size for AS, RA and PsA patients. • IL-17 level was correlated with disease activity in AS and RA patients. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
4. Serum Levels of OPG, RANKL, and RANKL/OPG Ratio in Patients with Ankylosing Spondylitis: A Systematic Review and Meta-analysis.
- Author
-
Chen, Mengya, Hu, Xingxing, Wu, Meng, Yang, Jiajia, Han, Renfang, Ma, Yubo, Zhang, Xu, Yuan, Yaping, Liu, Rui, Wang, Mengmeng, Jiang, Guangming, Deng, Jixiang, Xu, Shengqian, Xu, Jianhua, Shuai, Zongwen, and Pan, Faming
- Subjects
ANKYLOSING spondylitis ,META-analysis ,DISEASE duration ,SERUM ,CONFIDENCE intervals - Abstract
Objectives: To investigate the role of osteoprotegerin (OPG), receptor activator of nuclear factor-kB ligand (RANKL), and RANKL/OPG ratio in the pathogenesis of ankylosing spondylitis (AS). Methods: Studies that compared serum levels of OPG, RANKL, and RANKL/OPG ratio between AS patients and healthy controls were gathered. Pooled standardized mean differences (SMDs) with 95% confidence intervals (CIs) were calculated by the random-effects model. Results: Twenty studies containing 1592 AS patients and 1064 healthy controls were included in this meta-analysis. Serum levels of OPG, RANKL, and RANKL/OPG ratio in AS patients were significantly higher than that in normal controls (OPG: SMD = 0.401, 95%CI = 0.026–0.777, p = 0.036; RANKL: SMD = 1.116, 95%CI = 0.510–1.723, p < 0.001; RANKL/OPG ratio: SMD = 0.691, 95%CI = 0.084–1.299, p = 0.026, respectively). Subgroup analysis suggested that Asian AS patients and patients with elevated ESR (ESR >20 mm/h) had higher serum OPG levels compared to normal controls. Asian patients, CRP >10 mg/L, ESR >20 mm/h, duration of disease ≤8 years, and BASDAI score >4 points subgroups showed increased RANKL levels compared to controls. Conclusions: Serum levels of OPG, RANKL, and RANKL/OPG ratio may be used as potential susceptible biomarkers for AS, but they could be influenced by race, inflammatory factors, and disease activity of AS patients. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
5. Chronic obstructive pulmonary disease in rheumatoid arthritis: a systematic review and meta-analysis.
- Author
-
Ma, Yubo, Tong, Hui, Zhang, Xu, Wang, Mengmeng, Yang, Jiajia, Wu, Meng, Han, Renfang, Chen, Mengya, Hu, Xingxing, Yuan, Yaping, Pan, Guixia, Zou, Yanfeng, Xu, Shengqian, and Pan, Faming
- Subjects
OBSTRUCTIVE lung diseases ,META-analysis ,RHEUMATOID arthritis ,FIXED effects model ,RANDOM effects model - Abstract
Background: The risk and prevalence of chronic obstructive pulmonary disease (COPD) in rheumatoid arthritis (RA) is still obscure. The current study was aimed to systematically review and meta-analyse the risk ratio (RR) and prevalence of COPD in RA.Methods: A comprehensive systematic review was conducted based on PubMed, Web of Science and Cochrane Library from inception to April 30, 2018. The primary outcome of our study was the RR of COPD in RA patients compared with controls, and secondary was the prevalence of COPD in RA patients. Pooled effect sizes were calculated according to fixed effect model or random effects model depending on heterogeneity.Results: Six and eight studies reported the RR and prevalence of COPD in RA respectively. Compared with controls, RA patients have significant increased risk of incident COPD with pooled RR 1.82 (95% CI = 1.55 to 2.10, P < 0.001). The pooled prevalence of COPD in RA patients was 6.2% (95% CI = 4.1 to 8.3%). Meta-regression identified that publication year was an independent covariate negatively associated with the RR of COPD, and smoker proportion of RA population was also positively associated with the prevalence of COPD significantly in RA patients.Conclusions: The present meta-analysis has demonstrated the significant increased risk and high prevalence of COPD in RA patients. Patients with RA had better cease tobacco use and rheumatologists should pay attention to the monitoring of COPD for the prevention and control of COPD. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
6. Dickkopf-1 in ankylosing spondylitis: Review and meta-analysis.
- Author
-
Wu, Meng, Chen, Mengya, Ma, Yubo, Yang, Jiajia, Han, Renfang, Yuan, Yaping, Hu, Xingxing, Wang, Mengmeng, Zhang, Xu, Xu, Shengqian, Liu, Rui, Jiang, Guangming, Xu, Jianhua, Shuai, Zongwen, Zou, Yanfeng, Pan, Guixia, and Pan, Faming
- Subjects
- *
ANKYLOSING spondylitis treatment , *GLYCOPROTEINS , *META-analysis , *RADIOGRAPHIC processing , *DATABASES , *THERAPEUTICS - Abstract
Background Current findings regarding serum Dickkopf-1 (DKK-1) concentration in ankylosing spondylitis (AS) have proven inconsistent. This meta-analysis was performed to provide a better understanding of serum DKK-1 and AS. Methods Online electronic databases were used to retrieve all relevant articles published before November 2017. The pooled standardized mean difference (SMD) with 95% confidence interval (CI) was calculated by the random-effect model. Results 23 studies, containing 1348 AS patients and 909 healthy controls, were included in this meta-analysis. No significant difference in serum DKK-1 concentration was found between AS patients and healthy controls (pooled SMD = 0.488, 95%CI = −0.176 to 1.152, p = 0.150). Subgroup analyses suggested that serum DKK-1 in patients with increased C-reactive protein (CRP) (CRP > 10 mg/L) and high modified Stroke AS Spine Score (mSASSS) (mSASSS > 30) were significantly lower than healthy controls. Serum DKK-1 was, however, increased in patients with normal CRP (CRP ≤ 10 mg/L). Conclusion Although serum DKK-1 concentration was not significantly different in AS vs. healthy controls, it may be used as a biomarker of inflammation and radiographic damage in AS. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.